A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

Investigational Site Number : 1580003, Taichung

Investigational Site Number : 1580002, Tainan City

Investigational Site Number : 0320002, CABA

Investigational Site Number : 0360002, Richmond

Investigational Site Number : 3800002, Orbassano

Investigational Site Number : 7240003, Girona

Thomas Jefferson University Hospital Site Number : 8400009, Philadelphia

Thomas Jefferson University - North East Site Number : 8401009, Philadelphia

Investigational Site Number : 3800001, Rozzano

Investigational Site Number : 3800004, Milan

Investigational Site Number : 7240002, Madrid

Investigational Site Number : 7240001, Madrid

Investigational Site Number : 7240004, Madrid

Investigational Site Number : 2500003, Toulouse

Investigational Site Number : 3800005, Aviano (PN)

Investigational Site Number : 3800008, Padua

Investigational Site Number : 3800006, Bologna

Investigational Site Number : 2500001, Saint-Herblain

Investigational Site Number : 2500005, Paris

Investigational Site Number : 1520003, Temuco

Investigational Site Number : 1520004, Santiago

Investigational Site Number : 1520002, Santiago

Investigational Site Number : 1520005, Santaigo

Investigational Site Number : 1520001, Santiago

Investigational Site Number : 2500006, Bordeaux

Investigational Site Number : 1580005, Taipei

Investigational Site Number : 3920001, Sapporo

Investigational Site Number : 6160002, Poznan

Investigational Site Number : 6160001, Warsaw

Investigational Site Number : 6160003, Gdansk

Investigational Site Number : 6160004, Olsztyn

Investigational Site Number : 4100002, Seoul

Investigational Site Number : 4100003, Seoul

Investigational Site Number : 4100001, Seoul

Investigational Site Number : 7240006, Barcelona